These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impact of exercise on pulmonary artery pressure in patients with heart failure using an ambulatory pulmonary artery pressure monitor. Khedraki R; Abraham J; Jonsson O; Bhatt K; Omar HR; Bennett M; Bhimaraj A; Guha A; McCann P; Muse ED; Robinson M; Sauer AJ; Cheng A; Bagsic S; Fudim M; Heywood JT; Guglin M Front Cardiovasc Med; 2023; 10():1077365. PubMed ID: 36937902 [TBL] [Abstract][Full Text] [Related]
4. Effect of Metoprolol CR/XL on pulmonary artery pressure in chronic heart failure patients assessed by an implanted ultrasonic device with special emphasis on diurnal variation and exercise capacity. Parikh KH; Hetal A; Milan C; Urmil G; Hemang A; Anish C; Ajay M; Ake H; Ramesh K; Parloop A; Rozenman Y Indian Heart J; 2009; 61(1):34-9. PubMed ID: 19729686 [TBL] [Abstract][Full Text] [Related]
5. Effects of pressure variation and atrial fibrillation on CardioMEMS Wolfson AM; Yousefian O; Short L; O'Brien D; Talmor G; Qiu J; Yoon A; Fong M; Saxon L; Doshi R; Grazette L; Shavelle DM Physiol Meas; 2017 Jun; 38(6):1094-1103. PubMed ID: 28493849 [TBL] [Abstract][Full Text] [Related]
6. Multicenter registry and test bed for extended outpatient hemodynamic monitoring: the hemodynamic frontiers in heart failure (HF Heywood JT; Munshi K; Jordan T; Muse E; Fudim M; Sauer AJ; McDermott M; Shah H; Bhimaraj A; Khedraki R; Robinson MR; McCann P; Volz E; Guha A; Jonsson O; Bhatt KA; Bennett MK; Benjamin TA; Guglin M; Abraham J Front Cardiovasc Med; 2023; 10():1321415. PubMed ID: 38094114 [TBL] [Abstract][Full Text] [Related]
7. Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure: Results From the EMBRACE-HF Trial. Nassif ME; Qintar M; Windsor SL; Jermyn R; Shavelle DM; Tang F; Lamba S; Bhatt K; Brush J; Civitello A; Gordon R; Jonsson O; Lampert B; Pelzel J; Kosiborod MN Circulation; 2021 Apr; 143(17):1673-1686. PubMed ID: 33550815 [TBL] [Abstract][Full Text] [Related]
8. Ambulatory haemodynamic-guided management reduces heart failure hospitalizations in a multicentre European heart failure cohort. Dauw J; Sokolski M; Middleton JT; Nijst P; Dupont M; Forouzan O; Rothman AMK; Ruschitzka F; Flammer AJ; Mullens W ESC Heart Fail; 2022 Dec; 9(6):3858-3867. PubMed ID: 35916354 [TBL] [Abstract][Full Text] [Related]
9. Correlation between pulmonary artery pressure and thoracic impedance: Insights from daily monitoring through an implanted device in chronic heart failure. Perego GB; Oldani M; Pellegrini D; Brasca FMA; Malfatto G; Villani A; Brambilla R; Rella V; Parati G Int J Cardiol; 2017 Oct; 245():196-200. PubMed ID: 28735754 [TBL] [Abstract][Full Text] [Related]
10. Comparison of a radiofrequency-based wireless pressure sensor to swan-ganz catheter and echocardiography for ambulatory assessment of pulmonary artery pressure in heart failure. Verdejo HE; Castro PF; Concepción R; Ferrada MA; Alfaro MA; Alcaíno ME; Deck CC; Bourge RC J Am Coll Cardiol; 2007 Dec; 50(25):2375-82. PubMed ID: 18154961 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF). Angermann CE; Assmus B; Anker SD; Asselbergs FW; Brachmann J; Brett ME; Brugts JJ; Ertl G; Ginn G; Hilker L; Koehler F; Rosenkranz S; Zhou Q; Adamson PB; Böhm M; Eur J Heart Fail; 2020 Oct; 22(10):1891-1901. PubMed ID: 32592227 [TBL] [Abstract][Full Text] [Related]
12. Correlation of laboratory haemoconcentration measures with filling pressures obtained via pulmonary arterial pressure sensors in ambulatory heart failure patients. Almufleh A; Desai AS; Fay R; Ferreira JP; Buckley LF; Mehra MR; Rossignol P; Zannad F Eur J Heart Fail; 2020 Oct; 22(10):1907-1911. PubMed ID: 32353199 [TBL] [Abstract][Full Text] [Related]
13. Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension. Codina P; Domingo M; Barceló E; Gastelurrutia P; Casquete D; Vila J; Abdul-Jawad Altisent O; Spitaleri G; Cediel G; Santiago-Vacas E; Zamora E; Ruiz-Cueto M; Santesmases J; de la Espriella R; Pascual-Figal DA; Nuñez J; Lupón J; Bayes-Genis A ESC Heart Fail; 2022 Aug; 9(4):2170-2180. PubMed ID: 35588235 [TBL] [Abstract][Full Text] [Related]
14. Assessing the impact of haemodynamic monitoring with CardioMEMS on heart failure patients: a cost-benefit analysis. Codina P; Vicente Gómez JÁ; Hernández Guillamet G; Ricou Ríos L; Carrete A; Vilalta V; Estrada O; Ara J; Lupón J; Bayés-Genís A; López Seguí F ESC Heart Fail; 2024 Aug; 11(4):1955-1962. PubMed ID: 38500304 [TBL] [Abstract][Full Text] [Related]
15. Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study. Shavelle DM; Desai AS; Abraham WT; Bourge RC; Raval N; Rathman LD; Heywood JT; Jermyn RA; Pelzel J; Jonsson OT; Costanzo MR; Henderson JD; Brett ME; Adamson PB; Stevenson LW; Circ Heart Fail; 2020 Aug; 13(8):e006863. PubMed ID: 32757642 [TBL] [Abstract][Full Text] [Related]
16. Validating Left Ventricular Filling Pressure Measurements in Patients with Congestive Heart Failure: CardioMEMS™ Pulmonary Arterial Diastolic Pressure versus Left Atrial Pressure Measurement by Transthoracic Echocardiography. Tolia S; Khan Z; Gholkar G; Zughaib M Cardiol Res Pract; 2018; 2018():8568356. PubMed ID: 30116638 [TBL] [Abstract][Full Text] [Related]